Category: Medical/Health Care

April 17, 2018 Off

AstraZeneca Presents Imfinzi (durvalumab) Plus tremelimumab Combination Data at AACR Annual Meeting

By Web Desk

Phase Ib Study 006 long-term follow-up shows clinical activity in PD-L1 ≥25% and <25% groups in 2nd-line non-small cell lung cancer Phase I Study 10 data shows clinical activity with combination treatment in 2nd-line metastatic urothelial carcinoma CAMBRIDGE, United Kingdom, April 16, 2018 (GLOBE NEWSWIRE) — AstraZeneca and MedImmune, its global biologics research and development […]

March 1, 2018 Off

گڈسینڈ کا وٹامن کے2 نیو یارک کے ٹائمز اسکوائر اور پیرس ففٹین ڈسٹرکٹ پہنچ گیا، چینی فہم کی مضبوطی دنیا بھر میں لے جاتا ہوا

By Web Desk

شینچن، چین، 28 فروری 2018ء/پی آرنیوزوائر/– 2018ء کے آغاز پر گڈسینڈ فارما سائنس اینڈ ٹیکنالوجی کمپنی لمیٹڈ (“گڈسینڈ”) نے اپنے وٹامن برانڈ کے2 کی نیویارک کے ٹائمز اسکوائر پر نصب عظیم الجثہ بل بورڈز پر اور پیرس کے 15 ویں ضلع میں تشہیر کی۔ https://photos.prnasia.com/prnvar/20180228/2067856-1 وٹامن کے2 صحت عامہ کے عالمی اداروں کی جانب سے […]

February 28, 2018 Off

Goodscend’s Vitamin K2 Landed in New York Times Square and Paris Fifteen District, Delivering the Strength of China Intelligence to The World

By Web Desk

SHENZHEN, China, Feb. 28, 2018 /PRNewswire/ — At the beginning of 2018, Goodscend Pharm. Sci & Tech. Co., Ltd. (“Goodscend”) promoted its vitamin brand K2 on the large billboards overlooking New York’s Times Square and in the 15th arrondissement of Paris. Vitamin K2 is recognized by the global healthcare community as a revolutionary vitamin. In […]

February 14, 2017 Off

European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis

By Web Desk

Baricitinib, marketed as Olumiant, is the first JAK inhibitor approved to treat RA in the EU INDIANAPOLIS, Feb. 13, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the European Commission has granted marketing authorisation for Olumiant® (baricitinib) 4 mg and 2 mg film-coated tablets in Europe […]

January 23, 2017 Off

Sprint Acquires 33 Percent of TIDAL and Creates Game-Changing Partnership

By Web Desk

TIDAL and its artists to deliver exclusive content to help Sprint acquire new customers, reward current customers Sprint will make TIDAL available to its 45 million post and prepaid customers Sprint CEO Marcelo Claure to join TIDAL Board of Directors NEW YORK and OVERLAND PARK, Kansas, Jan. 23, 2017 /PRNewswire/ — Global music and entertainment platform […]